Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Plan B GAO Investigation Sought By House Members

This article was originally published in The Pink Sheet Daily

Executive Summary

Group led by Rep. Waxman is requesting that GAO examine communications between the White House and HHS regarding FDA's decision not to approve the Plan B emergency contraceptive switch application.
Advertisement

Related Content

FDA Comes Under Fire From Sen. Clinton Over Plan B Decision
FDA Comes Under Fire From Sen. Clinton Over Plan B Decision
Advisory Committee Member Viewpoints On Meeting Topics Should Be Part Of Vetting Process, GAO Says
Advisory Committee Member Viewpoints On Meeting Topics Should Be Part Of Vetting Process, GAO Says
Plan B Decision Mobilizes House Members To Seek FDA Integrity Review
Plan B OTC Submission Deemed "Not Approvable"
Plan B OTC Submission Deemed "Not Approvable"
FDA Postpones Plan B OTC Switch Decision Until May

Topics

Advertisement
UsernamePublicRestriction

Register

PS059432

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel